Glycoprotein 130 regulates bone turnover and bone size by distinct downstream signaling pathways
Natalie A. Sims(The University of Melbourne), T. John Martin(St Vincent's Hospital Melbourne), Matthias Ernst(Olivia Newton-John Cancer Wellness & Research Centre), Markus Glatt(Novartis (Switzerland)), Akira Nakamura(St Vincents Institute of Medical Research), Matthew T. Gillespie(Hudson Institute of Medical Research), J Quinn(The University of Melbourne), Brendan J. Jenkins(South Australia Pathology)
Cited by 196
Related Papers
Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand Families
|Endocrine Reviews|1999|2.3k
A family of cytokine-inducible inhibitors of signalling
|Nature|1997|2.1k
IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis
|Journal of Clinical Investigation|1999|1.7k
Tumor Necrosis Factor α Stimulates Osteoclast Differentiation by a Mechanism Independent of the Odf/Rankl–Rank Interaction
|The Journal of Experimental Medicine|2000|1.3k
Breast Cancer Cells Interact with Osteoblasts to Support Osteoclast Formation1
|Endocrinology|1999|536